Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Trial Active — Not Recruiting NCT04238299

Application of Functional Renal MRI to Improve Assessment of Chronic Kidney Disease

Application of Functional Renal MRI to Improve Assessment of Chronic Kidney Disease — Active Not Recruiting • Gastroenterology • NCT04238299.

📅 12 May 2026 ⏱ 1 min read
Active — Not Recruiting
Check the registry for current status and eligibility criteria.
Status
Active — Not Recruiting
NCT ID
NCT04238299
Start
2021-06-01
Completion
2027-02-28
ClinicaliQ Trial Snapshot
  • Application of Functional Renal MRI to Improve Assessment of Chronic Kidney Disease — Active Not Recruiting • Gastroenterology • NCT04238299.
  • MRI scan measures kidney structure and function to predict chronic kidney disease progression and guide treatment decisions.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Research question: Can multiparametric renal Magnetic Resonance Imaging (MRI) provide structural and functional assessment of the kidneys to deliver prognostic information and guide treatment options in chronic kidney disease (CKD)? Aims and objectives: 1. To establish a multiparametric renal MRI protocol in CKD cohorts. 2. To use multiparametric MRI to characterise people with and without CKD progression. 3. To compare multiparametric renal MRI with 'gold-standard' renal biopsy to determine pathological processes of CKD progression that are detectable by MRI. Conditions: Chronic Kidney Diseases Interventions: Multiparametric renal MRI Lead Sponsor: University…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Hepatitis B (Chronic): Diagnosis and Management (NICE NG133)
Gastroenterology · 27 Mar 2026
Assess all newly diagnosed chronic hepatitis B patients with HBsAg, anti-HBc, HBeAg, anti-HBe, quantitative HBV DNA, ALT, and liver function tests before…
View guideline →
Guideline
Cirrhosis in Over 16s: Assessment and Management (NICE NG50)
Gastroenterology · 27 Mar 2026
Perform upper endoscopy to screen all cirrhosis patients for oesophageal varices; if present, offer variceal band ligation and initiate non-selective beta-blockers (propranolol…
View guideline →
Guideline
Coeliac Disease: Recognition, Assessment and Management (NICE NG20)
Gastroenterology · 27 Mar 2026
Test for coeliac disease using tissue transglutaminase (tTG) IgA antibodies as first-line serology, with concurrent total IgA measurement; if IgA deficient, use…
View guideline →
Guideline
Irritable Bowel Syndrome in Adults: Diagnosis and Management (NICE CG61)
Gastroenterology · 27 Mar 2026
Offer structured dietary and lifestyle advice as first-line treatment, including consideration of a low FODMAP diet if standard measures are insufficient, before…
View guideline →
Clinical Brief
UKHSA and Stablepharma highlight breakthrough with fridge-free tetanus and diphtheria vaccine
Gastroenterology · UKHSA · 13 Mar 2026
Stablepharma has developed a thermostable tetanus and diphtheria vaccine requiring no cold-chain storage, addressing a critical logistical barrier to immunisation in resource-limited…
View brief →
Guideline
2022 ESPGHAN Guidelines on Coeliac Disease Diagnosis
Gastroenterology · 30 Mar 2026
This ESPGHAN guideline addresses 2022 ESPGHAN Guidelines on Coeliac Disease Diagnosis in Gastroenterology. Use it to review current recommendation wording, eligibility criteria,…
View guideline →